Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: September 2015

Chapter 12 - Assessing patient outcome and troubleshooting deep brain stimulation

Related content

Powered by UNSILO
1.Okun, MS, Tagliati, M, Pourfar, M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Archives of Neurology. 2005;62(8):1250–55.
2.Goetz, CG, Fahn, S, Martinez-Martin, P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Movement Disorders: Official Journal of the Movement Disorder Society. 2007;22(1):4147.
3.Morishita, T, Rahman, M, Foote, KD, et al. DBS candidates that fall short on a levodopa challenge test: alternative and important indications. The Neurologist. 2011;17(5):263–68.
4.Defer, GL, Widner, H, Marie, RM, Remy, P, Levivier, M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Movement Disorders: Official Journal of the Movement Disorder Society. 1999;14(4):572–84.
5.Germano, IM, Gracies, JM, Weisz, DJ, et al. Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. Journal of Neurosurgery. 2004;101(1):3642.
6.Loher, TJ, Burgunder, JM, Pohle, T, et al. Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. Journal of Neurosurgery. 2002;96(5):844–53.
7.Weaver, F, Follett, K, Hur, K, Ippolito, D, Stern, M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. Journal of Neurosurgery. 2005;103(6):956–67.
8.Williams, NR, Foote, KD, Okun, MS. STN vs. GPi deep brain stimulation: translating the rematch into clinical practice. Movement Disorders Clinical Practice. 2014;1(1):2435.
9.Blomstedt, P, Hariz, GM, Hariz, MI, Koskinen, LO. Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up. British Journal of Neurosurgery. 2007;21(5):504–09.
10.Koller, WC, Lyons, KE, Wilkinson, SB, Troster, AI, Pahwa, R. Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Movement Disorders: Official Journal of the Movement Disorder Society. 2001;16(3):464–68.
11.Vickrey, BG. Getting oriented to patient-oriented outcomes. Neurology. 1999;53(4):662–63.
12.Guyatt, GH, Bombardier, C, Tugwell, PX. Measuring disease-specific quality of life in clinical trials. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 1986;134(8):889–95.
13.Doward, LC, McKenna, SP. Defining patient-reported outcomes. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research. 2004;7(Suppl 1):S48.
14.Hayes, V, Morris, J, Wolfe, C, Morgan, M. The SF-36 health survey questionnaire: is it suitable for use with older adults? Age and Ageing. 1995;24(2):120–25.
15.Hill, S, Harries, U, Popay, J. Is the short form 36 (SF-36) suitable for routine health outcomes assessment in health care for older people? Evidence from preliminary work in community based health services in England. Journal of Epidemiology and Community Health. 1996;50(1):9498.
16.Hobson, JP, Meara, RJ. Is the SF-36 health survey questionnaire suitable as a self-report measure of the health status of older adults with Parkinson's disease? Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 1997;6(3):213–16.
17.Ware, JE Jr., Sherbourne, CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care. 1992;30(6):473–83.
18.Hunt, SM, McKenna, SP, McEwen, J, Williams, J, Papp, E. The Nottingham Health Profile: subjective health status and medical consultations. Social Science & Medicine Part A, Medical Sociology. 1981;15(3 Pt 1):221–29.
19.Kind, P, Carr-Hill, R. The Nottingham health profile: a useful tool for epidemiologists? Social Science & Medicine. 1987;25(8):905–10.
20.Bergner, M, Bobbitt, RA, Carter, WB, Gilson, BS. The Sickness Impact Profile: development and final revision of a health status measure. Medical Care. 1981;19(8):787805.
21.Welsh, M, McDermott, MP, Holloway, RG, et al. Development and testing of the Parkinson's disease quality of life scale. Movement Disorders: Official Journal of the Movement Disorder Society. 2003;18(6):637–45.
22.Kuehler, A, Henrich, G, Schroeder, U, et al. A novel quality of life instrument for deep brain stimulation in movement disorders. Journal of Neurology, Neurosurgery, and Psychiatry. 2003;74(8):1023–30.
23.Devlin, N, Williams, A. Valuing quality of life: results for New Zealand health professionals. The New Zealand Medical Journal. 1999;112(1083):6871.
24.Hobson, P, Holden, A, Meara, J. Measuring the impact of Parkinson's disease with the Parkinson's Disease Quality of Life questionnaire. Age and Ageing. 1999;28(4):341–46.
25.Jenkinson, C, Fitzpatrick, R, Argyle, M. The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. Social Science & Medicine. 1988;27(12):1411–14.
26.Wiklund, I. The Nottingham Health Profile – a measure of health-related quality of life. Scandinavian Journal of Primary Health Care Supplement. 1990;1:1518.
27.Hagell, P, Whalley, D, McKenna, SP, Lindvall, O. Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile. Movement Disorders: Official Journal of the Movement Disorder Society. 2003;18(7):773–83.
28.Hunt, SM, McKenna, SP. Validating the SF-36. BMJ. 1992;305(6854):645; author reply 6.
29.Sullivan, M, Karlsson, J, Ware, JE Jr. The Swedish SF-36 Health Survey – I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Social Science & Medicine. 1995;41(10):1349–58.
30.Den Oudsten, BL, Van Heck, GL, De Vries, J. The suitability of patient-based measures in the field of Parkinson's disease: a systematic review. Movement Disorders: Official Journal of the Movement Disorder Society. 2007;22(10):1390–401.
31.Thorsen, H, McKenna, S, Tennant, A, Holstein, P. Nottingham health profile scores predict the outcome and support aggressive revascularisation for critical ischaemia. European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery. 2002;23(6):495–99.
32.Troster, AI, Pahwa, R, Fields, JA, Tanner, CM, Lyons, KE. Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation. Parkinsonism & Related Disorders. 2005;11(6):367–73.
33.Damiano, AM, Snyder, C, Strausser, B, Willian, MK. A review of health-related quality-of-life concepts and measures for Parkinson's disease. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 1999;8(3):235–43.
34.Diamond, A, Jankovic, J. The effect of deep brain stimulation on quality of life in movement disorders. Journal of Neurology, Neurosurgery, and Psychiatry. 2005;76(9):1188–93.
35.Schulzer, M, Mak, E, Calne, SM. The psychometric properties of the Parkinson's Impact Scale (PIMS) as a measure of quality of life in Parkinson's disease. Parkinsonism & Related Disorders. 2003;9(5):291–94.
36.Calne, SM, Mak, E, Hall, J, et al. Validating a quality-of-life scale in caregivers of patients with Parkinson's disease: Parkinson's Impact Scale (PIMS). Advances in Neurology. 2003;91:115–22.
37.Jenkinson, C, Fitzpatrick, R, Peto, V, Greenhall, R, Hyman, N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age and Ageing. 1997;26(5):353–57.
38.Peto, V, Jenkinson, C, Fitzpatrick, R, Greenhall, R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 1995;4(3):241–48.
39.Blahak, C, Wohrle, JC, Capelle, HH, et al. Health-related quality of life in segmental dystonia is improved by bilateral pallidal stimulation. Journal of Neurology. 2008;255(2):178–82.
40.Halbig, TD, Gruber, D, Kopp, UA, et al. Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life. Journal of Neurology, Neurosurgery, and Psychiatry. 2005;76(12):1713–16.
41.Mueller, J, Skogseid, IM, Benecke, R, et al. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Movement Disorders: Official Journal of the Movement Disorder Society. 2008;23(1):131–34.
42.Skogseid, IM. Pallidal deep brain stimulation is effective, and improves quality of life in primary segmental and generalized dystonia. Acta Neurologica Scandinavica Supplementum. 2008;188:5155.
43.Vingerhoets, G, Lannoo, E, van der Linden, C, et al. Changes in quality of life following unilateral pallidal stimulation in Parkinson's disease. Journal of Psychosomatic Research. 1999;46(3):247–55.
44.Castelli, L, Perozzo, P, Zibetti, M, et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. European Neurology. 2006;55(3):136–44.
45.Funkiewiez, A, Ardouin, C, Caputo, E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2004;75(6):834–39.
46.Voon, V, Moro, E, Saint-Cyr, JA, Lozano, AM, Lang, AE. Psychiatric symptoms following surgery for Parkinson's disease with an emphasis on subthalamic stimulation. Advances in Neurology. 2005;96:130–47.
47.Odekerken, VJ, van Laar, T, Staal, MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurology. 2013;12(1):3744.
48.Mink, JW, Walkup, J, Frey, KA, et al. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Movement Disorders: Official Journal of the Movement Disorder Society. 2006;21(11):1831–38.
49.Rodriguez, RL, Fernandez, HH, Haq, I, Okun, MS. Pearls in patient selection for deep brain stimulation. The Neurologist. 2007;13(5):253–60.
50.Contarino, MF, Daniele, A, Sibilia, AH, et al. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2007;78(3):248–52.
51.Dujardin, K, Defebvre, L, Krystkowiak, P, Blond, S, Destee, A. Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease. Journal of Neurology. 2001;248(7):603–11.
52.Moretti, R, Torre, P, Antonello, RM, et al. Neuropsychological changes after subthalamic nucleus stimulation: a 12 month follow-up in nine patients with Parkinson's disease. Parkinsonism & Related Disorders. 2003;10(2):7379.
53.Schroeder, U, Kuehler, A, Haslinger, B, et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain: A Journal of Neurology. 2002;125(Pt 9):19952004.
54.Schupbach, WM, Chastan, N, Welter, ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. Journal of Neurology, Neurosurgery, and Psychiatry. 2005;76(12):1640–44.
55.Alegret, M, Junque, C, Valldeoriola, F, et al. Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Archives of Neurology. 2001;58(8):1223–27.
56.Morrison, CE, Borod, JC, Perrine, K, et al. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists. 2004;19(2):165–81.
57.Saint-Cyr, JA, Trepanier, LL, Kumar, R, Lozano, AM, Lang, AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain: A Journal of Neurology. 2000;123(Pt 10):2091–108.
58.Gironell, A, Kulisevsky, J, Rami, L, et al. Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study. Journal of Neurology. 2003;250(8):917–23.
59.De Gaspari, D, Siri, C, Di Gioia, M, et al. Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson's disease. Parkinsonism & Related Disorders. 2006;12(5):289–95.
60.De Gaspari, D, Siri, C, Landi, A, et al. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus. Journal of Neurology, Neurosurgery, and Psychiatry. 2006;77(4):450–53.
61.Williams, AE, Arzola, GM, Strutt, AM, et al. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism & Related Disorders. 2011;17(5):321–27.
62.Folstein, MF, Folstein, SE, McHugh, PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12(3):189–98.
63.Gardner, R Jr., Oliver-Munoz, S, Fisher, L, Empting, L. Mattis Dementia Rating Scale: internal reliability study using a diffusely impaired population. Journal of Clinical Neuropsychology. 1981;3(3):271–75.
64.D W. Wechsler Adult Intelligence Scale (WAIS-3R). Third ed. San Antonio, TX: Harcourt Assessment; 1997.
65.Lhermitte, F, Pillon, B, Serdaru, M. Human autonomy and the frontal lobes. Part I: Imitation and utilization behavior: a neuropsychological study of 75 patients. Annals of Neurology. 1986;19(4):326–34.
66.Nelson, HE. A modified card sorting test sensitive to frontal lobe defects. Cortex; A Journal Devoted to the Study of the Nervous System and Behavior. 1976;12(4):313–24.
67.Giovagnoli, AR, Del Pesce, M, Mascheroni, S, et al. Trail making test: normative values from 287 normal adult controls. Italian Journal of Neurological Sciences. 1996;17(4):305–09.
68.Miner, T, Ferraro, FR. The role of speed of processing, inhibitory mechanisms, and presentation order in trail-making test performance. Brain and Cognition. 1998;38(2):246–53.
69.Tombaugh, TN, Kozak, J, Rees, L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists. 1999;14(2):167–77.
70.Benton, AL, Hamsher, K. Multilingual Aphasia Examination. Iowa City, IA: AJA Associates; 1989.
71.Amodio, P, Wenin, H, Del Piccolo, F, et al. Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clinical and Experimental Research. 2002;14(2):117–31.
72.Arbuthnott, K, Frank, J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. Journal of Clinical and Experimental Neuropsychology. 2000;22(4):518–28.
73.Mascolo, MF, Hirtle, SC. Verbal coding and the elimination of Stroop interference in a matching task. The American Journal of Psychology. 1990;103(2):195215.
74.Van der Elst, W, Van Boxtel, MP, Van Breukelen, GJ, Jolles, J. Detecting the significance of changes in performance on the Stroop Color-Word Test, Rey's Verbal Learning Test, and the Letter Digit Substitution Test: the regression-based change approach. Journal of the International Neuropsychological Society: JINS. 2008;14(1):7180.
75.Flowers, KA, Robertson, C. The effect of Parkinson's disease on the ability to maintain a mental set. Journal of Neurology, Neurosurgery, and Psychiatry. 1985;48(6):517–29.
76.Wechsler Memory Scale. San Antonio, TX: The Psychological Corporation; 1997.
77.Owen, AM, Beksinska, M, James, M, et al. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia. 1993;31(7):627–44.
78.Cooper, JA, Sagar, HJ, Jordan, N, Harvey, NS, Sullivan, EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain: A Journal of Neurology. 1991;114(Pt 5):2095–122.
79.Tombaugh, TN. A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists. 2006;21(1):5376.
80.Wiens, AN, Fuller, KH, Crossen, JR. Paced Auditory Serial Addition Test: adult norms and moderator variables. Journal of Clinical and Experimental Neuropsychology. 1997;19(4):473–83.
81.Frank, RM, Byrne, GJ. The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia. International Journal of Geriatric Psychiatry. 2000;15(4):317–24.
82.Shapiro, AM, Benedict, RH, Schretlen, D, Brandt, J. Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. The Clinical Neuropsychologist. 1999;13(3):348–58.
83.Poreh, A. Analysis of mean learning of normal participants on the Rey Auditory–Verbal Learning Test. Psychological Assessment. 2005;17(2):191–99.
84.Ryan, JJ, Geisser, ME. Validity and diagnostic accuracy of an alternate form of the Rey Auditory Verbal Learning Test. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists. 1986;1(3):209–17.
85.Pillon, B, Deweer, B, Agid, Y, Dubois, B. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Archives of Neurology. 1993;50(4):374–79.
86.Cockburn, J. Performance on the Tower of London test after severe head injury. Journal of the International Neuropsychological Society: JINS. 1995;1(6):537–44.
87.Delis, DC, Kramer, JH, Kaplan, E, Holdnack, J. Reliability and validity of the Delis-Kaplan Executive Function System: an update. Journal of the International Neuropsychological Society: JINS. 2004;10(2):301–03.
88.Homack, S, Lee, D, Riccio, CA. Test review: Delis–Kaplan executive function system. Journal of Clinical and Experimental Neuropsychology. 2005;27(5):599609.
89.Calero, MD, Arnedo, ML, Navarro, E, Ruiz-Pedrosa, M, Carnero, C. Usefulness of a 15-item version of the Boston Naming Test in neuropsychological assessment of low-educational elders with dementia. The Journals of Gerontology Series B, Psychological Sciences and Social Sciences. 2002;57(2):P187–91.
90.Kent, PS, Luszcz, MA. A review of the Boston Naming Test and multiple-occasion normative data for older adults on 15-item versions. The Clinical Neuropsychologist. 2002;16(4):555–74.
91.Tombaugh, TN, Hubley, AM. The 60-item Boston Naming Test: norms for cognitively intact adults aged 25 to 88 years. Journal of Clinical and Experimental Neuropsychology. 1997;19(6):922–32.
92.Gladsjo, JA, Schuman, CC, Evans, JD, et al. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment. 1999;6(2):147–78.
93.Sunderland, T, Hill, JL, Mellow, AM, et al. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. Journal of the American Geriatrics Society. 1989;37(8):725–29.
94.Janvin, C, Aarsland, D, Larsen, JP, Hugdahl, K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dementia and Geriatric Cognitive Disorders. 2003;15(3):126–31.
95.Warrington, EK, James, M. The Visual Object and Space Perception Battery. Bury St Edmunds: Thames Valley Test Company; 1991.
96.Mason, CF, Ganzler, H. Adult norms for the Shipley Institute of Living Scale and Hooper Visual Organization Test based on age and education. Journal of Gerontology. 1964;19:419–24.
97.Merten, T, Beal, C. An analysis of the Hooper Visual Organization Test with neurological patients. The Clinical Neuropsychologist. 1999;13(4):521–9.
98.Schretlen, DJ, Pearlson, GD, Anthony, JC, Yates, KO. Determinants of Benton Facial Recognition Test performance in normal adults. Neuropsychology. 2001;15(3):405–10.
99.Starkstein, SE, Mayberg, HS, Preziosi, TJ, et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 1992;4(2):134–39.
100.Sockeel, P, Dujardin, K, Devos, D, et al. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2006;77(5):579–84.
101.Bruss, GS, Gruenberg, AM, Goldstein, RD, Barber, JP. Hamilton Anxiety Rating Scale Interview guide: joint interview and test-retest methods for interrater reliability. Psychiatry Research. 1994;53(2):191202.
102.Leentjens, AF, Verhey, FR, Lousberg, R, Spitsbergen, H, Wilmink, FW. The validity of the Hamilton and Montgomery–Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. International Journal of Geriatric Psychiatry. 2000;15(7):644–49.
103.Weintraub, D, Oehlberg, KA, Katz, IR, Stern, MB. Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry. 2006;14(2):169–75.
104.Visser, M, Leentjens, AF, Marinus, J, Stiggelbout, AM, van Hilten, JJ. Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2006;21(5):668–72.
105.Ertan, FS, Ertan, T, Kiziltan, G, Uygucgil, H. Reliability and validity of the Geriatric Depression Scale in depression in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2005;76(10):1445–47.
106.Biggs, JT, Wylie, LT, Ziegler, VE. Validity of the Zung Self-rating Depression Scale. The British Journal of Psychiatry: The Journal of Mental Science. 1978;132:381–85.
107.Thurber, S, Snow, M, Honts, CR. The Zung Self-Rating Depression Scale: convergent validity and diagnostic discrimination. Assessment. 2002;9(4):401–05.
108.Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA. A rating scale for mania: reliability, validity and sensitivity. The British Journal of Psychiatry: The Journal of Mental Science. 1978;133:429–35.
109.Steiner, M, Streiner, DL. Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials. Canadian Journal of Psychiatry: Revue canadienne de psychiatrie. 2005;50(6):327–32.
110.Goodman, WK, Price, LH, Rasmussen, SA, et al. The Yale–Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry. 1989;46(11):1012–16.
111.Goodman, WK, Price, LH, Rasmussen, SA, et al. The Yale–Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry. 1989;46(11):1006–11.
112.Kim, SW, Dysken, MW, Kuskowski, M. The Yale–Brown Obsessive–Compulsive Scale: a reliability and validity study. Psychiatry Research. 1990;34(1):99106.
113.Cummings, JL, Mega, M, Gray, K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–14.
114.Brandstaedter, D, Spieker, S, Ulm, G, et al. Development and evaluation of the Parkinson Psychosis Questionnaire. A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease. Journal of Neurology. 2005;252(9):1060–66.
115.Okun, MS, Foote, KD. A mnemonic for Parkinson disease patients considering DBS: a tool to improve perceived outcome of surgery. The Neurologist. 2004;10(5):290.
116.Okun, MS, Rodriguez, RL, Foote, KD, et al. A case-based review of troubleshooting deep brain stimulator issues in movement and neuropsychiatric disorders. Parkinsonism & Related Disorders. 2008;14(7):532–38.
117.Rughani, AI, Hodaie, M, Lozano, AM. Acute complications of movement disorders surgery: effects of age and comorbidities. Movement Disorders: Official Journal of the Movement Disorder Society. 2013;28(12):1661–67.
118.Mikos, A, Pavon, J, Bowers, D, et al. Factors related to extended hospital stays following deep brain stimulation for Parkinson's disease. Parkinsonism & Related Disorders. 2010;16(5):324–28.
119.Beric, A, Kelly, PJ, Rezai, A, et al. Complications of deep brain stimulation surgery. Stereotactic and Functional Neurosurgery. 2001;77(1–4):7378.
120.Fenoy, AJ, Simpson, RK Jr. Risks of common complications in deep brain stimulation surgery: management and avoidance. Journal of Neurosurgery. 2014;120(1):132–39.
121.Franzini, A, Cordella, R, Messina, G, et al. Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients. Journal of Neural Transmission. 2011;118(10):1497–510.
122.Hariz, MI. Complications of deep brain stimulation surgery. Movement Disorders: Official Journal of the Movement Disorder Society. 2002;17(Suppl 3):S162–66.
123.Hariz, MI, Fodstad, H. Do microelectrode techniques increase accuracy or decrease risks in pallidotomy and deep brain stimulation? A critical review of the literature. Stereotactic and Functional Neurosurgery. 1999;72(2–4):157–69.
124.Oh, MY, Abosch, A, Kim, SH, Lang, AE, Lozano, AM. Long-term hardware-related complications of deep brain stimulation. Neurosurgery. 2002;50(6):1268–74; discussion 74–76.
125.Seijo, FJ, Alvarez-Vega, MA, Gutierrez, JC, Fdez-Glez, F, Lozano, B. Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson's disease. Review of 272 procedures. Acta Neurochirurgica. 2007;149(9):867–75; discussion 76.
126.Umemura, A, Jaggi, JL, Hurtig, HI, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. Journal of Neurosurgery. 2003;98(4):779–84.
127.Voges, J, Volkmann, J, Allert, N, et al. Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. Journal of Neurosurgery. 2002;96(2):269–79.
128.Inci, S, Erbengi, A, Berker, M. Pulmonary embolism in neurosurgical patients. Surgical neurology. 1995;43(2):123–8; discussion 8–9.
129.Voges, J, Hilker, R, Botzel, K, et al. Thirty days complication rate following surgery performed for deep-brain-stimulation. Movement Disorders: Official Journal of the Movement Disorder Society. 2007;22(10):1486–89.
130.Krack, P, Batir, A, Van Blercom, N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. The New England Journal of Medicine. 2003;349(20):1925–34.
131.Volkmann, J, Allert, N, Voges, J, et al. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology. 2001;56(4):548–51.
132.Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. The New England Journal of Medicine. 2001;345(13):956–63.
133.Benabid, AL, Koudsie, A, Benazzouz, A, Le Bas, JF, Pollak, P. Imaging of subthalamic nucleus and ventralis intermediate of the thalamus. Movement Disorders: Official Journal of the Movement Disorder Society. 2002;17(Suppl 3):S123–29.
134.Hamani, C, Richter, E, Schwalb, JM, Lozano, AM. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery. 2005;56(6):1313–21; discussion 21–24.
135.Medtronic. Deep Brain Stimulation 3387/89 Lead Kit: Implant Manual. Minneapolis, MN: Medtronic, Inc.; 2000.
136.Lyons, KE, Wilkinson, SB, Overman, J, Pahwa, R. Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology. 2004;63(4):612–16.
137.Schwalb, JM, Riina, HA, Skolnick, B, et al. Revision of deep brain stimulator for tremor. Technical note. Journal of Neurosurgery. 2001;94(6):1010–12.
138.Sherif, C, Dorfer, C, Kalteis, K, et al. Deep brain pulse-generator and lead-extensions: subjective sensations related to measured parameters. Movement Disorders: Official Journal of the Movement Disorder Society. 2008;23(7):1036–40.
139.Alesch, F, Pinter, MM, Helscher, RJ, et al. Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochirurgica. 1995;136(1–2):7581.
140.Albanese, A, Nordera, GP, Caraceni, T, Moro, E. Long-term ventralis intermediate thalamic stimulation for parkinsonian tremor. Italian Registry for Neuromodulation in Movement Disorders. Advances in Neurology. 1999;80:631–34.
141.Kumar, K, Kelly, M, Toth, C. Deep brain stimulation of the ventral intermediate nucleus of the thalamus for control of tremors in Parkinson's disease and essential tremor. Stereotactic and Functional Neurosurgery. 1999;72(1):4761.
142.Limousin, P, Speelman, JD, Gielen, F, Janssens, M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. Journal of Neurology, Neurosurgery, and Psychiatry. 1999;66(3):289–96.
143.Benabid, AL, Pollak, P, Gao, D, et al. Chronic electrical stimulation of the ventralis intermediate nucleus of the thalamus as a treatment of movement disorders. Journal of Neurosurgery. 1996;84(2):203–14.
144.Deuschl, G, Herzog, J, Kleiner-Fisman, G, et al. Deep brain stimulation: postoperative issues. Movement Disorders: Official Journal of the Movement Disorder Society. 2006;21(Suppl 14):S219–37.
145.Limousin-Dowsey, P, Pollak, P, Van Blercom, N, et al. Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease. Journal of Neurology. 1999;246(Suppl 2):II4245.
146.Kleiner-Fisman, G, Fisman, DN, Sime, E, et al. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. Journal of Neurosurgery. 2003;99(3):489–95.
147.Tavella, A, Bergamasco, B, Bosticco, E, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2002;23(Suppl 2):S111–12.
148.Valldeoriola, F, Pilleri, M, Tolosa, E, et al. Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: long-term follow-up of patients. Movement Disorders: Official Journal of the Movement Disorder Society. 2002;17(1):125–32.
149.Kadowaki, T, Hashimoto, K, Suzuki, K, Watanabe, Y, Hirata, K. Case report: recurrent parkinsonism–hyperpyrexia syndrome following discontinuation of subthalamic deep brain stimulation. Movement Disorders: Official Journal of the Movement Disorder Society. 2011;26(8):1561–62.
150.Hocker, S, Kenney, DL, Ramar, K. Parkinsonism Hyperpyrexia Syndrome. Neurology Clinical Practice. 2013;3(6):535–38.
151.Herzog, J, Volkmann, J, Krack, P, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2003;18(11):1332–37.
152.Hariz, MI, Johansson, F, Shamsgovara, P, et al. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study. Movement Disorders: Official Journal of the Movement Disorder Society. 2000;15(1):136–39.
153.Doshi, PK, Chhaya, N, Bhatt, MH. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2002;17(5):1084–85.
154.Houeto, JL, Mesnage, V, Mallet, L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. Journal of Neurology, Neurosurgery, and Psychiatry. 2002;72(6):701–07.
155.Holmberg, B, Corneliusson, O, Elam, M. Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and of, autonomic dysfunction. Movement Disorders: Official Journal of the Movement Disorder Society. 2005;20(8):976–81.
156.Ostergaard, K, Sunde, N, Dupont, E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Movement Disorders: Official Journal of the Movement Disorder Society. 2002;17(4):693700.
157.Rodriguez-Oroz, MC, Obeso, JA, Lang, AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain: A Journal of Neurology. 2005;128(Pt 10):2240–49.
158.Krause, M, Fogel, W, Heck, A, et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. Journal of Neurology, Neurosurgery, and Psychiatry. 2001;70(4):464–70.
159.Voon, V, Hassan, K, Zurowski, M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology. 2006;67(7):1254–57.
160.Romito, LM, Scerrati, M, Contarino, MF, et al. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology. 2002;58(10):1546–50.
161.Kumar, R, Lang, AE, Rodriguez-Oroz, MC, et al. Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology. 2000;55(12 Suppl 6):S3439.
162.Sobstyl, M, Zabek, M, Kmiec, T, Slawek, J, Budohoski, KP. Status dystonicus due to internal pulse generator depletion in a patient with primary generalized dystonia. Movement Disorders: Official Journal of the Movement Disorder Society. 2014;29(2):188–89.
163.Boviatsis, EJ, Stavrinou, LC, Themistocleous, M, Kouyialis, AT, Sakas, DE. Surgical and hardware complications of deep brain stimulation. A seven-year experience and review of the literature. Acta Neurochirurgica. 2010;152(12):2053–62.
164.Umemura, A, Oka, Y, Yamamoto, K, et al. Complications of subthalamic nucleus stimulation in Parkinson's disease. Neurologia Medico-Chirurgica. 2011;51(11):749–55.
165.Palur, RS, Berk, C, Schulzer, M, Honey, CR. A metaanalysis comparing the results of pallidotomy performed using microelectrode recording or macroelectrode stimulation. Journal of Neurosurgery. 2002;96(6):1058–62.
166.Binder, DK, Rau, GM, Starr, PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery. 2005;56(4):722–32; discussion 732.
167.Sansur, CA, Frysinger, RC, Pouratian, N, et al. Incidence of symptomatic hemorrhage after stereotactic electrode placement. Journal of Neurosurgery. 2007;107(5):9981003.
168.Gorgulho, A, De Salles, AA, Frighetto, L, Behnke, E. Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. Journal of Neurosurgery. 2005;102(5):888–96.
169.Broderick, J, Connolly, S, Feldmann, E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke; A Journal of Cerebral Circulation. 2007;38(6):2001–23.
170.van den Bergh, WM, van der Schaaf, I, van Gijn, J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology. 2005;65(2):192–96.
171.Morcos, Z. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology. 2006;66(8):1284; author reply.
172.Morishita, T, Okun, MS, Burdick, A, Jacobson, CE, Foote, KD. Cerebral venous infarction: a potentially avoidable complication of deep brain stimulation surgery. Neuromodulation: Journal of the International Neuromodulation Society. 2013;16(5):407–13; discussion 413.
173.Ferro, JM, Canhao, P. Acute treatment of cerebral venous and dural sinus thrombosis. Current Treatment Options in Neurology. 2008;10(2):126–37.
174.Masuhr, F, Einhaupl, K. Treatment of cerebral venous and sinus thrombosis. Frontiers of Neurology and Neuroscience. 2008;23:132–43.
175.Zeng, L, Derex, L, Maarrawi, J, et al. Lifesaving decompressive craniectomy in ‘malignant’ cerebral venous infarction. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies. 2007;14(1):e2788.
176.Ferro, JM, Canhao, P, Bousser, MG, et al. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke; A Journal of Cerebral Circulation. 2008;39(4):1152–58.
177.Muir, KW. The PREVAIL trial and low-molecular-weight heparin for prevention of venous thromboembolism. Stroke; A Journal of Cerebral Circulation. 2008;39(7):2174–76.
178.Lee, AY, Levine, MN, Baker, RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. The New England Journal of Medicine. 2003;349(2):146–53.
179.Patrono, C, Baigent, C, Hirsh, J, Roth, G, American College of Chest Physicians. Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):199S233S.
180.Marik, PE. Aspiration pneumonitis and aspiration pneumonia. The New England Journal of Medicine. 2001;344(9):665–71.
181.Gologorsky, Y, Ben-Haim, S, Moshier, EL, et al. Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson disease increases the risk of adverse neurological sequelae. Neurosurgery. 2011;69(2):294–99; discussion 299–300.
182.Bronstein, JM, Tagliati, M, Alterman, RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Archives of Neurology. 2011;68(2):165.
183.Sillay, KA, Larson, PS, Starr, PA. Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery. 2008;62(2):360–66; discussion 366–367.
184.Levy, RM, Lamb, S, Adams, JE. Treatment of chronic pain by deep brain stimulation: long term follow-up and review of the literature. Neurosurgery. 1987;21(6):885–93.
185.Seal, LA, Paul-Cheadle, D. A systems approach to preoperative surgical patient skin preparation. American Journal of Infection Control. 2004;32(2):5762.
186.Miyagi, Y, Shima, F, Ishido, K. Implantation of deep brain stimulation electrodes in unshaved patients. Technical note. Journal of Neurosurgery. 2002;97(6):1476–78.
187.Masterson, TM, Rodeheaver, GT, Morgan, RF, Edlich, RF. Bacteriologic evaluation of electric clippers for surgical hair removal. American Journal of Surgery. 1984;148(3):301–02.
188.Hariz, MI, Johansson, F. Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency. Movement Disorders: Official Journal of the Movement Disorder Society. 2001;16(1):166–68.
189.Blomstedt, P, Hariz, MI. Hardware-related complications of deep brain stimulation: a ten year experience. Acta Neurochirurgica. 2005;147(10):1061–64; discussion 1064.
190.Baizabal Carvallo, JF, Mostile, G, Almaguer, M, et al. Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations. Stereotactic and Functional Neurosurgery. 2012;90(5):300–06.
191.Fernandez, FS, Alvarez Vega, MA, Antuna Ramos, A, Fernandez Gonzalez, F, Lozano Aragoneses, B. Lead fractures in deep brain stimulation during long-term follow-up. Parkinson's Disease. 2010;2010:409356.
192.Panov, F, Gologorsky, Y, Connors, G, et al. Deep brain stimulation in DYT1 dystonia: a 10-year experience. Neurosurgery. 2013;73(1):8693; discussion.
193.Tagliati, M, Krack, P, Volkmann, J, et al. Long-term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations. Movement Disorders: Official Journal of the Movement Disorder Society. 2011;26(Suppl 1):S5462.
194.Servello, D, Sassi, M, Gaeta, M, Ricci, C, Porta, M. Tourette syndrome (TS) bears a higher rate of inflammatory complications at the implanted hardware in deep brain stimulation (DBS). Acta Neurochirurgica. 2011;153(3):629–32.
195.Machado, AG, Hiremath, GK, Salazar, F, Rezai, AR. Fracture of subthalamic nucleus deep brain stimulation hardware as a result of compulsive manipulation: case report. Neurosurgery. 2005;57(6):E1318; discussion.
196.Cardoso, AF, Almeida, GM. Twiddler syndrome. Arquivos Brasileiros de Cardiologia. 2008;90(2):e15.
197.Dursun, I, Yesildag, O, Soylu, K, et al. Late pacemaker twiddler syndrome. Clinical Research in Cardiology: Official Journal of the German Cardiac Society. 2006;95(10):547–49.
198.Fahraeus, T, Hoijer, CJ. Early pacemaker twiddler syndrome. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2003;5(3):279–81.
199.Geissinger, G, Neal, JH. Spontaneous twiddler's syndrome in a patient with a deep brain stimulator. Surgical Neurology. 2007;68(4):454–56; discussion 456.
200.Farris, S, Vitek, J, Giroux, ML. Deep brain stimulation hardware complications: the role of electrode impedance and current measurements. Movement Disorders: Official Journal of the Movement Disorder Society. 2008;23(5):755–60.
201.Benezet-Mazuecos, J, Benezet, J, Ortega-Carnicer, J. Pacemaker Twiddler syndrome. European Heart Journal. 2007;28(16):2000.
202.Yianni, J, Nandi, D, Shad, A, et al. Increased risk of lead fracture and migration in dystonia compared with other movement disorders following deep brain stimulation. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia. 2004;11(3):243–45.
203.Favre, J, Taha, JM, Steel, T, Burchiel, KJ. Anchoring of deep brain stimulation electrodes using a microplate. Technical note. Journal of Neurosurgery. 1996;85(6):1181–83.
204.Fakhar, K, Hastings, E, Butson, CR, et al. Management of deep brain stimulator battery failure: battery estimators, charge density, and importance of clinical symptoms. PloS ONE. 2013;8(3):e58665.
205.Montuno, MA, Kohner, AB, Foote, KD, Okun, MS. An algorithm for management of deep brain stimulation battery replacements: devising a web-based battery estimator and clinical symptom approach. Neuromodulation: Journal of the International Neuromodulation Society. 2013;16(2):147–53.
206.Kiss, ZH, Anderson, T, Hansen, T, et al. Neural substrates of microstimulation-evoked tingling: a chronaxie study in human somatosensory thalamus. The European Journal of Neuroscience. 2003;18(3):728–32.
207.Ashby, P, Kim, YJ, Kumar, R, Lang, AE, Lozano, AM. Neurophysiological effects of stimulation through electrodes in the human subthalamic nucleus. Brain: A Journal of Neurology. 1999;122(Pt 10):1919–31.
208.Krack, P, Fraix, V, Mendes, A, Benabid, AL, Pollak, P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2002;17(Suppl 3):S188–97.
209.Tamma, F, Caputo, E, Chiesa, V, et al. Anatomo-clinical correlation of intraoperative stimulation-induced side-effects during HF-DBS of the subthalamic nucleus. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2002;23(Suppl 2):S109–10.
210.Baizabal-Carvallo, JF, Kagnoff, MN, Jimenez-Shahed, J, Fekete, R, Jankovic, J. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. Journal of Neurology, Neurosurgery, and Psychiatry. 2014;85(5):567–72.
211.Sriram, A, Ward, HE, Hassan, A, et al. Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease. Journal of Neurology. 2013;260(2):521–27.
212.Martinez-Ramirez, D, Giugni, J, Vedam-Mai, V, et al. The “brittle response” to Parkinson's disease medications: characterization and response to deep brain stimulation. PloS ONE. 2014;9(4):e94856.
213.Pinto, S, Gentil, M, Krack, P, et al. Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech. Movement Disorders: Official Journal of the Movement Disorder Society. 2005;20(11):1507–15.
214.Ramig, LO, Sapir, S, Countryman, S, et al. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up. Journal of Neurology, Neurosurgery, and Psychiatry. 2001;71(4):493–98.
215.Ramig, LO, Sapir, S, Fox, C, Countryman, S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls. Movement Disorders: Official Journal of the Movement Disorder Society. 2001;16(1):7983.
216.Sapir, S, Ramig, LO, Hoyt, P, et al. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment. Folia Phoniatrica et Logopaedica: Official Organ of the International Association of Logopedics and Phoniatrics. 2002;54(6):296303.
217.St George, RJ, Nutt, JG, Burchiel, KJ, Horak, FB. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology. 2010;75(14):1292–99.
218.Felice, KJ, Keilson, GR, Schwartz, WJ. ‘Rubral’ gait ataxia. Neurology. 1990;40(6):1004–05.
219.Limousin, P, Krack, P, Pollak, P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. The New England Journal of Medicine. 1998;339(16):1105–11.
220.Voon, V, Kubu, C, Krack, P, Houeto, JL, Troster, AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Movement Disorders: Official Journal of the Movement Disorder Society. 2006;21(Suppl 14):S305–27.
221.Castrioto, A, Lhommee, E, Moro, E, Krack, P. Mood and behavioural effects of subthalamic stimulation in Parkinson's disease. Lancet Neurology. 2014;13(3):287305.
222.Massano, J, Garrett, C. Deep brain stimulation and cognitive decline in Parkinson's disease: a clinical review. Frontiers in Neurology. 2012;3:66.
223.Perestelo-Perez, L, Rivero-Santana, A, Perez-Ramos, J, et al. Deep brain stimulation in Parkinson's disease: meta-analysis of randomized controlled trials. Journal of Neurology. 2014;261:2051–60.
224.Molinuevo, JL, Valldeoriola, F, Tolosa, E, et al. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Archives of Neurology. 2000;57(7):983–88.
225.Higuchi, MA, Tsuboi, Y, Inoue, T, et al. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease. Neuromodulation: Journal of the International Neuromodulation Society. 2015;18:113–17.
226.Kim, YE, Kim, HJ, Kim, HJ, et al. Impulse control and related behaviors after bilateral subthalamic stimulation in patients with Parkinson's disease. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia. 2013;20(7):964–69.
227.Moum, SJ, Price, CC, Limotai, N, et al. Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome. PloS ONE. 2012;7(1):e29768.
228.Weintraub, D, Koester, J, Potenza, MN, et al. Impulse control disorders in Parkinson disease. A cross-sectional study of 3090 patients. Archives of Neurology. 2010;67(5):589–95.
229.Albin, RL, Young, AB, Penney, JB. The functional anatomy of basal ganglia disorders. Trends in Neurosciences. 1989;12(10):366–75.
230.Pazo, JH, Belforte, JE. Basal ganglia and functions of the autonomic nervous system. Cellular and Molecular Neurobiology. 2002;22(5–6):645–54.
231.Sauleau, P, Raoul, S, Lallement, F, et al. Motor and non motor effects during intraoperative subthalamic stimulation for Parkinson's disease. Journal of Neurology. 2005;252(4):457–64.
232.Kaufmann, H, Bhattacharya, KF, Voustianiouk, A, Gracies, JM. Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson disease. Neurology. 2002;59(10):1657–58.
233.Ashkan, K, Samuel, M, Reddy, P, Ray Chaudhuri, K. The impact of deep brain stimulation on the nonmotor symptoms of Parkinson's disease. Journal of Neural Transmission. 2013;120(4):639–42.
234.Hwynn, N, Ul Haq, I, Malaty, IA, et al. Effect of deep brain stimulation on Parkinson's nonmotor symptoms following unilateral DBS: a pilot study. Parkinson's Disease. 2011;2011:507416.
235.Seif, C, Herzog, J, van der Horst, C, et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Annals of Neurology. 2004;55(1):118–20.
236.Winge, K, Nielsen, KK. Bladder dysfunction in advanced Parkinson's disease. Neurourology and Urodynamics. 2012;31(8):1279–83.
237.Fritsche, HM, Ganzer, R, Schlaier, J, et al. Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2009;24(10):1553–54.
238.Thobois, S, Mertens, P, Guenot, M, et al. Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. Journal of Neurology. 2002;249(5):529–34.
239.Esselink, RA, de Bie, RM, de Haan, RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology. 2004;62(2):201–07.
240.Troche, MS, Brandimore, AE, Foote, KD, Okun, MS. Swallowing and deep brain stimulation in Parkinson's disease: a systematic review. Parkinsonism & Related Disorders. 2013;19(9):783–88.
241.Troche, MS, Brandimore, AE, Foote, KD, et al. Swallowing outcomes following unilateral STN vs. GPi surgery: a retrospective analysis. Dysphagia. 2014;29:425–31.
242.Bejjani, BP, Gervais, D, Arnulf, I, et al. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. Journal of Neurology, Neurosurgery, and Psychiatry. 2000;68(5):595600.
243.Castelli, L, Perozzo, P, Genesia, ML, et al. Sexual well being in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Journal of Neurology, Neurosurgery, and Psychiatry. 2004;75(9):1260–64.
244.Romito, LM, Raja, M, Daniele, A, et al. Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society. 2002;17(6):1371–74.
245.Jimenez-Jimenez, FJ, Sayed, Y, Garcia-Soldevilla, MA, Barcenilla, B. Possible zoophilia associated with dopaminergic therapy in Parkinson disease. The Annals of Pharmacotherapy. 2002;36(7–8):1178–79.
246.Klos, KJ, Bower, JH, Josephs, KA, Matsumoto, JY, Ahlskog, JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism & Related Disorders. 2005;11(6):381–86.
247.Ivanco, LS, Bohnen, NI. Effects of donepezil on compulsive hypersexual behavior in Parkinson disease: a single case study. American Journal of Therapeutics. 2005;12(5):467–68.
248.Barichella, M, Marczewska, AM, Mariani, C, et al. Body weight gain rate in patients with Parkinson's disease and deep brain stimulation. Movement Disorders: Official Journal of the Movement Disorder Society. 2003;18(11):1337–40.
249.Macia, F, Perlemoine, C, Coman, I, et al. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight. Movement Disorders: Official Journal of the Movement Disorder Society. 2004;19(2):206–12.
250.Montaurier, C, Morio, B, Bannier, S, et al. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. Brain: A Journal of Neurology. 2007;130(Pt 7):1808–18.
251.Kirschman, DL, Milligan, B, Wilkinson, S, et al. Pallidotomy microelectrode targeting: neurophysiology-based target refinement. Neurosurgery. 2000;46(3):613–22; discussion 622–24.
252.Biousse, V, Newman, NJ, Carroll, C, et al. Visual fields in patients with posterior GPi pallidotomy. Neurology. 1998;50(1):258–65.
253.Favilla, CG, Ullman, D, Wagle Shukla, A, et al. Worsening essential tremor following deep brain stimulation: disease progression versus tolerance. Brain: A Journal of Neurology. 2012;135(Pt 5):1455–62.
254.Lang, AE, Houeto, JL, Krack, P, et al. Deep brain stimulation: preoperative issues. Movement Disorders: Official Journal of the Movement Disorder Society. 2006;21(Suppl 14):S171–96.
255.Moro, E, Lang, AE. Criteria for deep-brain stimulation in Parkinson's disease: review and analysis. Expert Review of Neurotherapeutics. 2006;6(11):1695–705.
256.Hughes, AJ, Daniel, SE, Ben-Shlomo, Y, Lees, AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain: A Journal of Neurology. 2002;125(Pt 4):861–70.
257.Charles, PD, Van Blercom, N, Krack, P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology. 2002;59(6):932–34.
258.Schuepbach, WM, Rau, J, Knudsen, K, et al. Neurostimulation for Parkinson's disease with early motor complications. The New England Journal of Medicine. 2013;368(7):610–22.
259.Mestre, TA, Shah, P, Marras, C, Tomlinson, G, Lang, AE. Another face of placebo: the lessebo effect in Parkinson disease: meta-analyses. Neurology. 2014;82(16):1402–09.
260.Okun, MS, Fernandez, HH, Pedraza, O, et al. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology. 2004;63(1):161–63.
261.Marjama-Lyons, J, Okun, MS. Parkinson Disease: Guide to Deep Brain Stimulation. Hagerstown, MD: National Parkinson Foundation; 2007.
262.Kronenbuerger, M, Fromm, C, Block, F, et al. On-demand deep brain stimulation for essential tremor: a report on four cases. Movement Disorders: Official Journal of the Movement Disorder Society. 2006;21(3):401–05.
263.Guridi, J, Rodriguez-Oroz, MC, Alegre, M, Obeso, JA. Hardware complications in deep brain stimulation: electrode impedance and loss of clinical benefit. Parkinsonism & Related Disorders. 2012;18(6):765–69.